TY - JOUR
T1 - Diagnostic dilemma of patients with methylmalonic aciduria
T2 - Experience from a tertiary care centre in Pakistan
AU - Majid, Hafsa
AU - Jafri, Lena
AU - Khan, Aysha Habib
AU - Ali, Zeba Zulfiqar
AU - Jamil, Azeema
AU - Yusufzai, Nasir
AU - Fatimah, Midhat
AU - Afroze, Bushra
N1 - Publisher Copyright:
© 2018, Pakistan Medical Association. All rights reserved.
PY - 2018/4
Y1 - 2018/4
N2 - Objective: To determine the frequency of disorders leading to methylmalonic acidurias. Methods: This cross-sectional study was conducted from January 2013 to April 2016 at the Aga Khan University Hospital, Karachi, and comprised patients diagnosed with methylmalonic acidurias based on urine organic acid analysis. Clinical history and biochemical data was collected from the biochemical genetics laboratory requisition forms. Organic acid chromatograms of all the subjects were critically reviewed by a biochemical pathologist and a metabolic physician. For assessing the clinical outcome, medical charts of the patients were reviewed. SPSS 19 was used for data analysis. Results: Of the 1,778 patients 50(2.81%) were detected with methylmalonic acidurias. After excluding patients with non-significant peaks of methylmalonic acidemia, 41(2.31%) were included in the final analysis. Of these, 20(48.7%) were females, while the overall median age was 11.5 months (interquartile range: 6-41.5). On stratification by type of disorders leading to methylmalonic acidurias, 9(22%) had methylmalonic acidemia, 12(29%) had Cobalamin-related remethylation disorders, nonspecific methylmalonic acidurias in 16(39%), while 2(5%) each had succinyl coenzyme A synthetase and Vitamin B12 deficiency. respectively. Conclusion: Screening tests, including urine organic acid, provided valuable clues to the aetiology of methylmalonic acidurias.
AB - Objective: To determine the frequency of disorders leading to methylmalonic acidurias. Methods: This cross-sectional study was conducted from January 2013 to April 2016 at the Aga Khan University Hospital, Karachi, and comprised patients diagnosed with methylmalonic acidurias based on urine organic acid analysis. Clinical history and biochemical data was collected from the biochemical genetics laboratory requisition forms. Organic acid chromatograms of all the subjects were critically reviewed by a biochemical pathologist and a metabolic physician. For assessing the clinical outcome, medical charts of the patients were reviewed. SPSS 19 was used for data analysis. Results: Of the 1,778 patients 50(2.81%) were detected with methylmalonic acidurias. After excluding patients with non-significant peaks of methylmalonic acidemia, 41(2.31%) were included in the final analysis. Of these, 20(48.7%) were females, while the overall median age was 11.5 months (interquartile range: 6-41.5). On stratification by type of disorders leading to methylmalonic acidurias, 9(22%) had methylmalonic acidemia, 12(29%) had Cobalamin-related remethylation disorders, nonspecific methylmalonic acidurias in 16(39%), while 2(5%) each had succinyl coenzyme A synthetase and Vitamin B12 deficiency. respectively. Conclusion: Screening tests, including urine organic acid, provided valuable clues to the aetiology of methylmalonic acidurias.
KW - Cobalamin related remethylation disorders
KW - Methylmalonic aciduria
KW - Methylmalonyl-CoA mutase deficiency
KW - Pakistan
KW - Vitamin B 12 deficiency
UR - http://www.scopus.com/inward/record.url?scp=85044170883&partnerID=8YFLogxK
M3 - Article
C2 - 29808036
AN - SCOPUS:85044170883
SN - 0030-9982
VL - 68
SP - 510
EP - 514
JO - Journal of the Pakistan Medical Association
JF - Journal of the Pakistan Medical Association
IS - 4
ER -